↓ Skip to main content

Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma

Overview of attention for article published in Experimental Hematology & Oncology, July 2019
Altmetric Badge

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
Published in
Experimental Hematology & Oncology, July 2019
DOI 10.1186/s40164-019-0138-9
Pubmed ID
Authors

Ravi Potluri, Sandip Ranjan, Hitesh Bhandari, Helen Johnson, Andriy Moshyk, Srividya Kotapati

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 7 21%
Researcher 4 12%
Other 3 9%
Student > Ph. D. Student 1 3%
Student > Doctoral Student 1 3%
Other 2 6%
Unknown 15 45%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 15%
Pharmacology, Toxicology and Pharmaceutical Science 3 9%
Medicine and Dentistry 3 9%
Agricultural and Biological Sciences 2 6%
Mathematics 1 3%
Other 4 12%
Unknown 15 45%